Subscribe To
roivant to report financial results for the second quarter ended september 30, 2023, and provide business update on monday, november 13, 2023
BASEL, LONDON, and NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) — roivant (Nasdaq: ROIV) today announced ...
October 30, 2023, 9:30 pm
A biotech firm founded by vivek ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that pfizer gave it for free
Roche acquired a bowel-disease treatment from roivant for over $7 billion, the Wall Street Journal repo...
October 24, 2023, 3:19 pm
roivant sciences: risk-transforming deal met with crickets
Roche Holding AG acquires Telavant Holdings for $7.1B upfront and $150M milestone payment, potentially very interesting deal. ...
October 24, 2023, 9:25 am
roivant sciences sells joint venture with pfizer to roche for $7.1 billion
London-based biotech firm roivant Sciences (ROIV) agreed to sell its Telavant Holdings unit, which is c...
October 23, 2023, 3:25 pm
roivant, pfizer shares rise as roche agrees to buy immunology company for $7.1 billion
Shares of roivant Sciences Ltd. ROIV, -1.13% and Pfizer Inc. PFE, -1.73% gained ground premarket on Mon...
October 23, 2023, 8:36 am
Roche agrees $7.1 billion for drug company
It will buy immunology company Telavant Holdings from roivant Sciences and Pfizer....
October 23, 2023, 5:40 am
Roche enters into a definitive agreement to acquire telavant including rights to novel tl1a directed antibody (rvt-3101) for the treatment of inflammatory bowel disease from roivant
Roche will gain the rights to develop, manufacture and commercialize RVT-3101 in the US and Japan for the treatment of inflammatory bowel disease and ...
October 23, 2023, 5:00 am
Roche splashes us$7.1 billion on new irritable bowel drug
Roche has agreed to pay US$7.1 billion for an early-stage inflammatory bowel disease treatment developed by US rivals ...
October 23, 2023, 4:44 am
Roche buys telavant holdings for $7.1 billion
Roche on Monday said it will buy Telavant, a developer of a new treatment for inflamatory bowel diseases, for an initial $7.1 billion from American bi...
October 23, 2023, 1:37 am
3 no-brainer growth stocks to buy in october
October has typically been a solid month for stocks. CRISPR Therapeutics, DraftKings, and roivant Scien...
October 1, 2023, 8:30 am
roivant sciences ltd. (roiv) moves 21.6% higher: will this strength last?
roivant Sciences Ltd. (ROIV) saw its shares surge in the last session with trading volume being higher ...
September 27, 2023, 6:01 am
roivant stock could go higher on monetization potential of ‘blockbuster' assets
roivant shares finished more than 20% higher on Tuesday after Immunovant, in which ...
September 26, 2023, 4:59 pm
roivant announces positive initial imvt-1402 phase 1 sad and 300 mg subcutaneous mad results
IMVT-1402 subcutaneous (SC) doses achieved peak Immunoglobulin G (IgG) reductions that are similar to those previously observed with batoclimab No dec...
September 26, 2023, 10:00 am
Immunovant and roivant jump as new drug shapes up to become blockbuster
There was a bumper boost for stock in two Nasdaq-listed biotechs premarket after an experimental antibody treatment was revealed to have blockbuster p...
September 26, 2023, 9:28 am
roivant sciences: is this vivek ramaswamy's biotech stock a buy?
roivant Sciences (NASDAQ: ROIV) stock price has entered a major bull run as investors remain optimistic...
September 9, 2023, 11:17 am
2 supercharged growth stocks billionaires can't stop buying
Baker Bros. Advisors has been steadily buying Acadia Pharmaceuticals and roivant Sciences this year....
August 28, 2023, 6:00 pm
roivant sciences ltd. (roiv) q1 2023 earnings call transcript
roivant Sciences Ltd. (NASDAQ:ROIV ) Q1 2023 Earnings Conference Call August 14, 2023 8:00 AM ET Compan...
August 14, 2023, 8:20 pm
roivant sciences earnings come in below street estimates despite vtama sales growth
roivant Sciences shares traded modestly higher after the inflammation and immunology-focused biopharmac...
August 14, 2023, 10:47 am
2 magnificient growth stocks i'm buying in august
Growth stocks have returned to form this year. roivant Sciences and Viking Therapeutics are two growth ...
August 2, 2023, 11:15 am
2 nasdaq stocks that could soar this week
BridgeBio Pharma is slated to announce late-stage results for an important pipeline candidate on Monday. roiva...
July 16, 2023, 8:00 pm